Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Comabella

Showing results (21-30 of 263) with videos related to

Pageof 27
Sort By:
Pharmacogenomics|August 18, 2010
IFN-beta pharmacogenomics in multiple sclerosisKoen Vandenbroeck, Elena Urcelay, Manuel Comabella
Journal of Neuroimmunology|April 9, 2011
Tumor necrosis factor alpha (TNF-α), anti-TNF-α and demyelination revisited: an ongoing storyAna Caminero, Manuel Comabella, Xavier Montalban
Methods in Molecular Biology (Clifton, N.J.)|June 30, 2014
DNA Vaccination TechniquesNicolás Fissolo, Xavier Montalban, Manuel Comabella
Frontiers in Immunology|November 4, 2024
Big data and artificial intelligence applied to blood and CSF fluid biomarkers in multiple sclerosisGeorgina Arrambide, Manuel Comabella, Carmen Tur
Neurology(R) Neuroimmunology & Neuroinflammation|December 9, 2020
Chitinases and chitinase-like proteins as biomarkers in neurologic disordersRucsanda Pinteac, Xavier Montalban, Manuel Comabella
Clinical Immunology (Orlando, Fla.)|December 18, 2010
DNA-based vaccines for multiple sclerosis: current status and future directionsNicolas Fissolo, Xavier Montalban, Manuel Comabella
CNS Drugs|January 14, 2016
Teriflunomide in Patients with Relapsing-Remitting Forms of Multiple SclerosisAndrew Chan, Jérôme de Seze, Manuel Comabella
Frontiers in Immunology|January 8, 2025
EBV-specific T-cell immunity: relevance for multiple sclerosisMalina Behrens, Manuel Comabella, Jan D Lünemann
Handbook of Clinical Neurology|November 8, 2017
Multiple sclerosis, and other demyelinating and autoimmune inflammatory diseases of the central nervous systemClara Matute-Blanch, Xavier Montalban, Manuel Comabella
Current Opinion in Neurology|April 15, 2016
Precision medicine in multiple sclerosis: biomarkers for diagnosis, prognosis, and treatment responseManuel Comabella, Jaume Sastre-Garriga, Xavier Montalban
Pageof 27

Showing results (21-30 of 263) with videos related to

Sort By:
Pageof 27
Pharmacogenomics|August 18, 2010
IFN-beta pharmacogenomics in multiple sclerosisKoen Vandenbroeck, Elena Urcelay, Manuel Comabella
Journal of Neuroimmunology|April 9, 2011
Tumor necrosis factor alpha (TNF-α), anti-TNF-α and demyelination revisited: an ongoing storyAna Caminero, Manuel Comabella, Xavier Montalban
Methods in Molecular Biology (Clifton, N.J.)|June 30, 2014
DNA Vaccination TechniquesNicolás Fissolo, Xavier Montalban, Manuel Comabella
Frontiers in Immunology|November 4, 2024
Big data and artificial intelligence applied to blood and CSF fluid biomarkers in multiple sclerosisGeorgina Arrambide, Manuel Comabella, Carmen Tur
Neurology(R) Neuroimmunology & Neuroinflammation|December 9, 2020
Chitinases and chitinase-like proteins as biomarkers in neurologic disordersRucsanda Pinteac, Xavier Montalban, Manuel Comabella
Clinical Immunology (Orlando, Fla.)|December 18, 2010
DNA-based vaccines for multiple sclerosis: current status and future directionsNicolas Fissolo, Xavier Montalban, Manuel Comabella
CNS Drugs|January 14, 2016
Teriflunomide in Patients with Relapsing-Remitting Forms of Multiple SclerosisAndrew Chan, Jérôme de Seze, Manuel Comabella
Frontiers in Immunology|January 8, 2025
EBV-specific T-cell immunity: relevance for multiple sclerosisMalina Behrens, Manuel Comabella, Jan D Lünemann
Handbook of Clinical Neurology|November 8, 2017
Multiple sclerosis, and other demyelinating and autoimmune inflammatory diseases of the central nervous systemClara Matute-Blanch, Xavier Montalban, Manuel Comabella
Current Opinion in Neurology|April 15, 2016
Precision medicine in multiple sclerosis: biomarkers for diagnosis, prognosis, and treatment responseManuel Comabella, Jaume Sastre-Garriga, Xavier Montalban
Pageof 27